Bioorganic and Medicinal Chemistry Letters p. 5474 - 5477 (2005)
Update date:2022-08-03
Topics:
Pan, Weitao
Liu, Hu
Xu, Yong-Jiang
Chen, Xin
Kim, Ki Hwan
Milligan, Daniel L.
Columbus, John
Hadari, Yaron R.
Kussie, Paul
Wong, Wai C.
Labelle, Marc
Pyrimido-oxazepine based sub-micromolar inhibitors (2-4) for Aurora and FLT-3 were designed and synthesized. These preliminary results supported the potential use of pyrimido-oxazepines as a versatile template for developing specific kinase inhibitors.
View Morewebsite:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Contact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
SHUNYUANSHENG BIO-PHARMTECH CO., LTD
website:https://www.whsysbio.com
Contact:--
Address:Building 13, Liandong U Valley-Wuhan Economic Innovation Valley, No. 259, Xingsan Road, Shamao Street, Hannan District, Wuhan City, Hubei Province
Fujian Huitian Biological Pharmacy Co., Ltd.
Contact:0086-598-8300831; 8339920
Address:No.46,Taijiang Road,Sanming City,Fujian,China
Doi:10.1557/JMR.2000.0200
(1926)Doi:10.1016/j.bmcl.2009.12.012
(2010)Doi:10.1016/j.bmcl.2010.07.062
(2010)Doi:10.1039/P19720002795
(1972)Doi:10.1002/hlca.200690062
(2006)Doi:10.1139/V05-237
(2006)